Phase II trial of thalidomide in refractory/relapsed diffuse large B-cell lymphoma and Hodgkin's disease
Phase of Trial: Phase II
Latest Information Update: 12 May 2009
At a glance
- Drugs Thalidomide (Primary)
- Indications Hodgkin's disease; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 12 May 2009 Additional lead trial investigator Heffner LT identified as reported by ClinicalTrials.gov.
- 12 May 2009 Actual patient number (2) added as reported by ClinicalTrials.gov.
- 14 Nov 2006 Status change